Sacituzumab govitecan for treatment-refractory metastatic breast cancer

Aditya Bardia, MD, MPH, of Massachusetts General Hospital, Boston, MA, discusses the promising efficacy data of sacituzumab govitecan, an anti-Trop-2/SN-38 antibody-drug conjugate (ADC), for treatment... Author: VJOncology Added: 08/03/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts